You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 11, November 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Endocrine Surgery
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Clinically Significant Pancreatic Fistulas

Tetsuji Fujita, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Despite its suboptimal retrospective design, the article by Veillette and colleagues1 in the May issue of the Archives illustrating the clinical importance and updated management of pancreatic fistulas after pancreaticoduodenectomy provides critical information for practicing surgeons. The patient data were prospectively collected in a high-volume hospital, where about 106 pancreaticoduodenectomies are performed annually. In their study, a pancreatic fistula was identified when there was continuous external drainage for 7 days or an intraabdominal collection of amylase-rich fluid. The authors divided pancreatic fistulas into low-impact fistulas, which could usually be treated on an outpatient basis with favorable consequences (n = 26), and high-impact fistulas, which resulted in major morbidity and/or mortality despite rigorous intervention (n = 46). High-impact fistulas were divided into overt (n = 33) and occult (n = 13) fistulas. Occult fistulas were defined as those that were not manifest in the first postoperative week but subsequently resulted in fistula-related major morbidity. High-impact pancreatic . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Implications and Management of Pancreatic Fistulas Following Pancreaticoduodenectomy: The Massachusetts General Hospital Experience
Gregory Veillette, Ismael Dominguez, Cristina Ferrone, Sarah P. Thayer, Deborah McGrath, Andrew L. Warshaw, and Carlos Fernández-del Castillo
Arch Surg. 2008;143(5):476-481.
ABSTRACT | FULL TEXT  

RELATED LETTER

Clinically Significant Pancreatic Fistulas—Reply
Gregory Veillette and Carlos Fernández-del Castillo
Arch Surg. 2008;143(11):1132-1133.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.